oncology

  1. Roche's Tarceva versus Lilly's Verzenio

    Eli Lilly announces results of the Phase 3 JUNIPER trial study for Verzenio. Lilly gets a setback.
  2. Big setback for Lilly

    Verzenio fails and Levi Garraway says the outcome is unfortunate.
  3. Patent dispute win

    Lilly wins Alimta patent challenge. Also, Lilly had won Alimta patent battle against Actavis in July 2017.
  4. FDA approves Verzenio

    FDA says okay to Eli Lilly's breast cancer drug Verzenio.
  5. Clovis Oncology buyout true?

    Rumors say that Lilly to acquire Clovis Oncology.
  6. Huge Cuts in Oncology

    Announced today.
  7. Celgene to present data in ESMO 2017

    Celgene presenting data for Abraxane at ESMO 2017.
  8. Oncology expansion

    hi. I have an interview this week in the ONC division/rare disease. Trying to weed through this site to see if anyone can give their honest opinion without just being totally nasty. I like the products but wanted to see how the employee moral is and check to see if Novartis is treating their...
  9. Pulmonology/Neurology Specialty Question

    There is an opening for a pulmonology/neurology specialty position near me and I'm just wondering--what are the products that are promoted in this position? Thank you so much for any help. I literally just got laid off and have some experience with pulmonologists and neurologists so I want...